Fort Collins, CO – GenoFAB, a Colorado State University startup, has joined BioMADE, a non-profit public-private partnership dedicated to securing America’s future through bioindustrial manufacturing innovation, education, and collaboration. This strategic membership connects GenoFAB with BioMADE’s nationwide network of over 300 member organizations working collectively to solve critical biomanufacturing challenges. By joining this Manufacturing Innovation Institute (MII), GenoFAB becomes part of a diverse consortium committed to developing sustainable, bio-based products and manufacturing processes.
“BioMADE unites leaders across industry, government, and academia to build the foundation for a thriving domestic bioindustrial manufacturing sector,” said Jean Peccoud, Founder of GenoFAB. “We are excited to collaborate with fellow members to help shape the future of biomanufacturing and contribute our genetic design capabilities to this important national initiative.”
The development of effective biomanufacturing processes hinges on precisely engineering the microorganisms that transform raw feedstocks into valuable final products. GenoFAB’s expertise in this critical area represents a significant contribution to BioMADE’s mission. By applying advanced genetic design tools and methodologies, GenoFAB enables the creation and optimization of microbial cell factories that can efficiently convert renewable resources into sustainable chemicals, materials, and fuels.
“The ability to rapidly engineer microorganisms with specific metabolic capabilities is a cornerstone of industrial biomanufacturing,” explained Jean Peccoud. “Our plasmid design and management solutions help streamline this process, reducing development timelines and improving reproducibility across the biomanufacturing pipeline.”
This partnership strengthens GenoFAB’s commitment to advancing the bioeconomy through more efficient genetic design and data-driven product development strategies that support scalable biomanufacturing solutions. GenoFAB’s specialized capabilities in genetic design and plasmid construction directly align with BioMADE’s goal of transforming manufacturing processes for everyday products through biological innovation.
As the biomanufacturing industry continues to evolve, the need for standardized genetic tools and robust design frameworks becomes increasingly critical. GenoFAB’s systematic approach to developing and managing genetic resources addresses these needs, offering BioMADE members access to technologies that can accelerate the transition from laboratory concept to commercial-scale production.
GenoFAB’s participation in BioMADE underscores its dedication to driving innovation, developing industry standards, and supporting life scientists working at the critical intersection of research and commercial applications.
About GenoFAB
GenoFAB empowers life scientists and biotechnology companies to accelerate research and product development by delivering precisely engineered plasmids when they’re needed most. The company eliminates the risks associated with poor plasmid management—including unexpected delays, cost overruns, quality control issues, and commercialization roadblocks—allowing scientists to focus on discovery and companies to concentrate on their core business objectives. GenoFAB provides comprehensive plasmid management services spanning the entire lifecycle, from initial design through distribution and commercialization.
Media ContactCompany Name: GenoFAB, IncContact Person: Jean PeccoudEmail: Send EmailCountry: United StatesWebsite: https://genofab.com
